Trial intelligence / Profile preview

High-dose capsaicin patch (NGX-4010) for postherpetic neuralgia

NCT00034710Phase 2Completed

Sponsor
NeurogesX
Start
Mar 2002
Countries
1
01

Overview

A Phase 2 trial of capsaicin 8% patch in postherpetic neuralgia (PHN), sponsored by NeurogesX. Started Mar 2002; status: completed.

02

Drugs

capsaicin 8% patch
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on NCT00034710.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00034710.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call